tiprankstipranks
Trending News
More News >
Carisma Therapeutics (CARM)
NASDAQ:CARM

Carisma Therapeutics (CARM) Revenue

Compare
1,580 Followers

Carisma Therapeutics Revenue

Carisma Therapeutics had a revenue of 3.38M in the quarter ending Sep 30, 2024, with -63.19%. This bring the company's revenue in the last twelve months to 20.27M, Increased -2.13%. In the fiscal year ending Dec 31, 2023, Carisma Therapeutics had annual revenue of 14.92M with 51.71% growth.
Revenue (ttm)
20.27M
Revenue Growth
31.59%
P/S Ratio
0.58
Revenue/Employee
$139,430
Employees
107
Market Cap
$8.65M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 202314.92M5.08M+51.71%
Dec 31, 20229.83M-16.71M-62.95%
Dec 31, 202126.54M15.31M+136.24%
Dec 31, 202011.24M+∞%
Dec 31, 20190.00
Dec 31, 20180.00-425.00K-100.00%
Dec 31, 2017425.00K-29.56M-98.58%
Dec 31, 201629.98M28.99M+2,928.38%
Dec 31, 2015990.00K-1.25M-55.86%
Dec 31, 20142.24M909.00K+68.14%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis